Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04145193
Title Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.